Literature DB >> 18539267

A web-based tool for the assessment of discrimination and calibration properties of prognostic models.

Azzam F G Taktak1, Antonio Eleuteri, Stephen P Lake, Anthony C Fisher.   

Abstract

Prognostic models are developed to assist clinicians in making decisions regarding treatment and follow-up management. The accuracy of these models is often assessed either in terms of their discrimination performance or calibration but rarely both. In this paper, we describe the development of an online tool for discrimination using Harrell C index and calibration using a Hosmer-Lemeshow type analysis (http://clinengnhs.liv.ac.uk/AADP/AADP_Welcome.htm). We show examples of using the tool on real data. We highlight situations where the model performed well in terms of either discrimination or calibration but not both depending on the sample size of the test set. We conclude that prognostic models should be assessed both in terms of discrimination and calibration and that calibration analysis should be carried out numerically and graphically.

Mesh:

Year:  2008        PMID: 18539267     DOI: 10.1016/j.compbiomed.2008.04.005

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  3 in total

1.  Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancer.

Authors:  Reiki Nishimura; Tomofumi Osako; Yasuyuki Nishiyama; Rumiko Tashima; Masahiro Nakano; Mamiko Fujisue; Yasuo Toyozumi; Nobuyuki Arima
Journal:  Mol Clin Oncol       Date:  2014-08-22

2.  Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study.

Authors:  Rumiko Tashima; Reiki Nishimura; Tomofumi Osako; Yasuyuki Nishiyama; Yasuhiro Okumura; Masahiro Nakano; Mamiko Fujisue; Yasuo Toyozumi; Nobuyuki Arima
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

3.  Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?

Authors:  Mattia C F Prosperi; Sarah L Ingham; Anthony Howell; Fiona Lalloo; Iain E Buchan; Dafydd Gareth Evans
Journal:  BMC Med Inform Decis Mak       Date:  2014-10-01       Impact factor: 2.796

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.